On the other-hand, USA legalization will be a boon to Valens shareholders. They are well positioned to turn USA acquisitions into THC selling product companies.
They will also benefit from being able to set up operations in each country to product what they currently produce in the other. Their SKU portfolio in each country will expand dramatically.
The Indiva bet is can the edibles sector continue to expand in real dollars, and as a percentage of THC sales in Canada, while they maintain their lock on selling nearly 50% of all Canadian edibles.
If so their PPS rises to over 50¢ and I have a double.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM